PRESS RELEASE: May 10, 2017
New Horizon Biotech, NHB, closes initial round of funding
The executive management team of New Horizon Biotechnology (NHB) announced today the closing of the companies first round of investment.
The present round of capital will allow New Horizon Biotechnology to complete prototype and product development and conduct performance studies of a patented single-use microbial fermentor design for biopharmaceutical applications.
New Horizon Biotechnology (NHB) is a privately held corporation located in Bethlehem, Pennsylvania, USA. NHB has developed and is preparing to deploy a patented fermenter system, SUHF™, that enables more flexible, cost effective, and reproducible production for biotechnology and pharmaceutical customers.